PortfoliosStock ScreensStocksStockXcel

Humacyte Inc

HUMAW | US

0.09

USD

-0.01

-7.31%

HUMAW | US

About Humacyte Inc

Sector

Healthcare

Industry

Biotechnology

Earnings date

30/06/2024

As of date

20/03/2026

Close

0.09

Open

0.09

High

0.10

Low

0.09

Humacyte Inc. a clinical-stage biotechnology platform company develops and manufactures off-the-shelf bioengineered human tissues. The company develops and manufactures acellular tissues to address life- and limb-threatening vascular conditions for complex organ disease. Its Human Acellular Vessel (HAV) a regenerative vascular conduit that is in late-stage clinical trials targeting multiple vascular applications including vascular trauma repair arteriovenous access for hemodialysis and peripheral arterial disease. The company was founded in 2004 and is based in Durham North Carolina.

View Less

HUMAW | US

Risk
173.8
Sharpe
-0.51
Luna's Score
34/100
Recommendation
Sell

Luna says (HUMAW | US)

What's Working

Low Debt to Equity (< 0.25)

Strong Revenue Growth (> 10%)

What's not Working

Negative Momentum (Declining Price)

Weakness based on declining price with high volume

Price Below SMA10D

High Short-term Volatility

High 6-Month Volatility (>65%)

High Current Volume and Negative 1-Day Return

Microcap (<300M USD)

High Market Beta (> 0.8)

Weak Sharpe Ratio (< 0.3)

Volatility Signals

Bullish: Stable Volatility (6-month <= 1-month volatility) is positive for the stock performance.

Risk Meter

10 days

153.7%

1 month

173.8%

3 months

150.8%

6 months

146.2%

Returns

Fundamental Ratios

PE

-

Fwd. PE

-

Price to book

-

Debt to equity

-0.63

Debt to assets

0.13

Ent. to EBITDA

-

Ent. to rev.

-

PEG

-

Other Fundamentals

EBITDA

-99.65M

MarketCap

-

MarketCap(USD)

-

Div. yield

-

Op. margin

-

Erngs. growth

-

Rev. growth

248.50

Ret. on equity

-850.81

Short ratio

-

Short perc.

-

Market Sentiment (SMA and Price signals)

Short-term: Bearish (SMA10D < SMA1M)

Intermediate-term: Bearish (SMA1M < SMA3M)

Long-term: Bearish (SMA6M < SMA12M)

SMAs: Stock Price Trends

Range10D

0.03

Range1M

0.04

Range3M

0.07

Volumes: Market Activity

Rel. volume

5.12

Price X volume

3.89K

Peers

Name
Ticker
Industry
Close
Marketcap
Day Return
PE Ratio
Debt to Equity
 
 
 
 
 
 
 
 
XOMAPXOMAPBiotechnology25.60-0.58%26.27121.93%
XOMA Corporation Depositary Shares Rep Series B 8.375% Cumulative Preferred StockXOMAOBiotechnology25.330-0.04%25.57121.93%
Revolution Medicines Inc. WarrantRVMDWBiotechnology1.60-15.34%n/a5.40%
Rocket Pharmaceuticals Inc. WarrantRCKTWBiotechnology0.01580-21.00%n/a0.00%
ICUCWICUCWBiotechnology0.02610n/a-45.50%
EyeGate Pharmaceuticals IncEYEGBiotechnology34.96460-0.98%n/a
COEPWCOEPWBiotechnology0.0121022.22%n/a25.11%
  • 1

Diversifiers

Name
Ticker
Industry
Close
Marketcap
Day Return
PE Ratio
Debt to Equity
 
 
 
 
 
 
 
 
No data

Industry Comparison

ParameterCompanyIndustryIndicator
Enterprise to EBITDA---
Ent. to Revenue---
PE Ratio-41.03-
Price to Book-15.55-
Dividend Yield---
Std. Deviation (3M)150.78-Riskier
Debt to Equity-0.63-1.23Expensive
Debt to Assets0.130.25Cheaper
Market Cap---
  • 1

Unlock Your Investing Potential

Register with Xstocks

Join over 2,000+ Investors

Register now and embark on your journey to informed and successful investing.

Explore Industry Correlations

Explore Industry Correlations

Uncover Trading and Hedging Opportunities

Gain valuable insights into potential trading opportunities and discover strategic hedging possibilities

Discover Top-Performing Industries

Discover Top performing Industries

Explore Stocks for Short and Long-Term Gains

Uncover opportunities at both short-term and long-term horizons, allowing you to make informed investment decisions.

Follow us @XStocks007